Clinical Microbiology and Infection

Papers
(The H4-Index of Clinical Microbiology and Infection is 66. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-01-01 to 2025-01-01.)
ArticleCitations
Postvaccination infections among staff of a tertiary care hospital after vaccination with severe acute respiratory syndrome coronavirus 2 vector and mRNA-based vaccines657
Lysosomal alkalization to potentiate eradication of intra-osteoblastic Staphylococcus aureus in the bone and joint infection setting620
Six-month antibody response to SARS-CoV-2 in healthcare workers assessed by virus neutralization and commercial assays577
Abandoned trials in infection diseases and clinical microbiology: a call for action518
Five versus seven days of nitrofurantoin for urinary tract infections in women with diabetes: a retrospective cohort study500
SARS-CoV-2 specific T-cell immunity in COVID-19 convalescent patients and unexposed controls measured by ex vivo ELISpot assay486
Acquired fluconazole resistance and genetic clustering in Diutina (Candida) catenulata from clinical samples334
Industry-sponsored research funding to infectious disease physicians in the United States between 2013 and 2021329
Changes in the gut microbiota and risk of colonization by multidrug-resistant bacteria, infection, and death in critical care patients306
How to verify and validate a clinical microbiology test before it can be used in routine diagnostics: a practical guide288
Vaccines alone will not prevent COVID-19 outbreaks among migrant workers—the example of meat processing plants268
Quantifying the impact of COVID-19-related restrictions on antibiotic resistance258
Myxovirus resistance protein A for discriminating between viral and bacterial lower respiratory tract infections in children – The TREND study238
A dosing nomograph for cerebrospinal fluid penetration of meropenem applied by continuous infusion in patients with nosocomial ventriculitis236
Re: ‘The renal safety of a single dose of gentamicin in patients with sepsis in the emergency department’ - Author’s reply233
The role of the computerized tomography scanner in the cross-transmission of carbapenem-resistant Acinetobacter baumannii between hospitalized patients215
Is it time for clinical trials of invasive group A and groups C and G Streptococcus infections?204
Amantadine for COVID-19 treatment (ACT) study: a randomized, double-blinded, placebo-controlled clinical trial197
Mycotic aneurysm of the infrarenal abdominal aorta infected by Mycoplasma hyorhinis diagnosed with direct 16S ribosomal DNA sequencing174
Limitations of classification and regression tree analysis in vancomycin exposure–response relationship studies: insights from data simulation155
Re: Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil by Ranzani et al.146
Re: Heterologous Gam-COVID-Vac (Sputnik V)/mRNA-1273 (Moderna) vaccination143
Re: Accelerating clinical trial implementation in the context of the COVID-19 pandemic by Diallo et al143
Re: ‘Seven versus 14-days course of antibiotics for the treatment of bloodstream infections by Enterobacterales’ by Molina et al.142
How to: Diagnose inborn errors of intrinsic and innate immunity to viral, bacterial, mycobacterial, and fungal infections141
Re: ‘the unique COVID-19 presentation of patients with B cell depletion’ by Belkin et al.138
Re: ‘Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients’ by Fiolet et al.136
Negative SARS-CoV-2 antibodies, T-cell response and virus neutralization following full vaccination in a renal transplant recipient: a call for vigilance130
SARS-CoV-2 antibodies in healthcare workers in a large university hospital, Kerala, India127
Vancomycin-resistant Enterococcus faecium: admission prevalence, sequence types and risk factors–a cross-sectional study in seven German university hospitals from 2014 to 2018116
Title Page115
Publishing Information110
Outside Front Cover107
Title Page106
Has the COVID-19 pandemic wiped out the seasonality of outpatient antibiotic use and influenza activity? A time-series analysis from 2014 to 2021104
Prophylaxis for COVID-19: a systematic review104
Re: Diagnostic limitations and challenges in current clinical guidelines and potential application of metagenomic sequencing to manage pulmonary invasive fungal infections in patients with haematologi103
Safety and immunogenicity of the epicutaneous reactivation of pertussis toxin immunity in healthy adults: a phase I, randomized, double-blind, placebo-controlled trial103
‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply100
Risk factors for candidaemia in hospitalized patients with liver cirrhosis: a multicentre case–control–control study99
Clinical and laboratory features of Strongyloides stercoralis infection at diagnosis and after treatment: a systematic review and meta-analysis99
Omicron (B.1.1.529) SARS-CoV-2 viral load among nasopharyngeal and oral samples compared to other variants of concern and impact on diagnostic testing strategy98
Characteristics, management and outcome of Herpes Simplex and Varicella-Zoster virus encephalitis: a multicentre prospective cohort study97
The effects of single and multiple resistance mechanisms on bacterial response to meropenem96
Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis93
In vivo fitness of carbapenem-resistant Acinetobacter baumannii strains in murine infection is associated with treatment failure in human infections93
Agreement of respiratory viruses' detection between nasopharyngeal swab and bronchoalveolar lavage in adults admitted for pneumonia: a retrospective study90
Selective reporting of antibiotic susceptibility testing results: less is more89
Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study88
Anaphylaxis due to anisakidosis86
Resistance mutations in SARS-CoV-2 omicron variant in patients treated with sotrovimab80
In vitro susceptibility to delafloxacin of Pseudomonas aeruginosa with resistance to other quinolones (ciprofloxacin and levofloxacin)77
Time to negative PCR conversion amongst high-risk patients with mild-to-moderate Omicron BA.1 and BA.2 COVID-19 treated with sotrovimab or nirmatrelvir77
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.76
Which trial do we need? Doxycycline in combination with ceftriaxone for the treatment of community-acquired pneumonia76
Development and validation of a novel death risk stratification scale in patients with hemorrhagic fever with renal syndrome: a 14-year ambispective cohort study75
The effect of a third BNT162b2 vaccine on breakthrough infections in health care workers: a cohort analysis74
A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality72
Treatment outcomes and risk factors for an unsuccessful outcome among patients with highly drug-resistant tuberculosis in Ukraine72
Expected phenotypes and expert rules are important complements to antimicrobial susceptibility testing71
A case of fatal monkeypox infection: necropsy and molecular findings, with some considerations related to clinical management71
Penicillin V versus amoxicillin for pneumonia in children—a Swedish nationwide emulated target trial68
Intravenous metronidazole for fulminant Clostridioides difficile infection68
Lower (1,3)-β-D-glucan sensitivity and in vitro levels in Candida auris and Candida parapsilosis strains: author's response68
Expanding evidence for shortened treatment of latent tuberculosis infection: progress, not perfection67
Quantifying the long-term effects of measles infection—a retrospective cohort study67
0.74200987815857